Quarter3/2019 Differentiate Million THB % Million THB % Million THB % Revenues Revenues from sales of real estate 3,224.7 79.9 3,153.6 86.9 ( 71.1 ) (2.2) Revenues from project management 433.7 10.7 358.4

unit of warrant for 1 ordinary share. In this regard, market price per share of the Company’s ordinary shares under the Terms and Conditions of MACO-W2 means trade value of the Company’s ordinary shares

DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 1 of 3 No. DOD026/2563 February 26, 2020 Subject Management Discussion and Analysis of for

equivalent to 60.9% of total sales, lower than Q2’2016, which had total cost of sales 62.7% of total sales due to efficient cost management and higher cost efficiency from better utilization of production

increase in total assets of Bt216 million from the December 31, 2016 was due mainly to an increase of Bt177 million for the value of trade receivable and other receivable, an increase of Bt108 million of

(31.1% of total revenues), and also the increasing revenue from other income, including trademark and trade name fees of DEAN & DELUCA of 85.1 Million Baht. The total gross profits in Q2 2017 was 761.8

percent compared to year 2015, due to decrease of salary, employment benefit, doubtful accounts, fees and other administrative expenses which are in line with the Company’s organizational management as

increase of salary, employment benefit, doubtful accounts, fees and other administrative expenses which are in line with the Company’s organizational management as aforementioned details. 5. Finance Costs

equipment acquired for the new factory (Phase 3) and a decline of Bt25 million in of trade receivable and other receivable. Total Liabilities Total liabilities decreased from Bt7,300 million at the end of

trade receivables of 2.84 million Baht and other receivables of 0.03 million Baht. Such estimation are based on the Company’s regulations related accounting policy. Details of debtors with estimated